US
drugs giant AbbVie has raised its takeover offer for UK rival Shire to £30.1bn
($51.3bn) in its latest attempt to persuade the firm to agree a deal.
The
share and cash offer equates to £51.15 a share and is 11% higher than AbbVie's
previous offer made in June, which Shire said undervalued the firm.
AbbVie
chief executive Richard Gonzalez said the increased proposal was "a
compelling offer".
It
is AbbVie's fourth attempt to buy Shire, a drug maker for rare diseases.
"[This
offer] creates immediate and
